Fc{gamma}RIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation

33Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

These studies investigate how interactions between the BCR and FcγRIIB affect B lymphocyte stimulator (BLyS) receptor expression and signaling. Previous studies showed that BCR ligation up-regulates BLyS binding capacity in mature B cells, reflecting increased BLyS receptor levels. Here we show that FcγRIIB coaggregation dampens BCR-induced BLyS receptor up-regulation. This cross-regulation requires BCR and FcγRIIB coligation, and optimal action relies on the Src-homology-2 (SH2)-containing inositol 5 phosphase-1 (SHIP1). Subsequent to FcγRIIB/BCR coaggregation, the survival promoting actions of BLyS are attenuated, reflecting reduced BLyS receptor signaling capacity in terms of Pim 2 maintenance, noncanonical NF-κB activation, and Bcl-xL levels. These findings link the negative regulatory functions of FcγRIIB with BLyS-mediated B-cell survival. © 2009 by The American Society of Hematoloty.

Cite

CITATION STYLE

APA

Crowley, J. E., Stadanlick, J. E., Cambier, J. C., & Cancro, M. P. (2009). Fc{gamma}RIIB signals inhibit BLyS signaling and BCR-mediated BLyS receptor up-regulation. Blood, 113(7), 1464–1473. https://doi.org/10.1182/blood-2008-02-138651

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free